A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of Lesinurad in Healthy Male Japanese Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2013
At a glance
- Drugs Lesinurad (Primary)
- Indications Gout
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 May 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Mar 2013 Planned End Date changed from 1 Jan 2013 to 1 May 2013 as reported by ClinicalTrials.gov.
- 06 Mar 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.